Physician profile
Jade Gallimore
NPI 1538556386
$1,623.88
in general payments reported to CMS, 2019-2025
15 companies · $846 in 2025
The $846 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $130 · 2023: $258 · 2024: $390 · 2025: $846.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,129 · Education: $365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,129.31 |
| Education | $364.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $539.06 | 2024-2025 | Stratafix, Vistaseal, Echelon Flex |
| Dilon Technologies, INC. | $169.58 | 2025 | Hemoblast Bellows |
| Kerecis Limited | $150.27 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Bone Support INC. | $129.14 | 2024 | Cerament G, Ceramentbone Void Filler |
| Merck Sharp & Dohme LLC | $115.63 | 2024-2025 | Keytruda, Lynparza |
| Janssen Pharmaceuticals, INC | $92.91 | 2024 | Xarelto |
| Kci USA, INC. | $92.83 | 2021 | |
| Abbvie INC. | $84.75 | 2023 | |
| Myriad Genetic Laboratories, INC. | $52.42 | 2024 | Myrisk |
| Smith+Nephew, INC. | $49.34 | 2021-2025 | Collagenase Santyl |
| Novartis Pharmaceuticals Corporation | $48.79 | 2023-2025 | |
| Hologic Sales and Service, LLC | $42.27 | 2025 | Magtrace, Sentimag |
| Solventum Corporation | $21.60 | 2025 | V.A.C.Ulta |
| Bayer Healthcare Pharmaceuticals INC. | $19.68 | 2024 | |
| Medtronic, INC. | $15.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jade Gallimore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.